Chlorpheniramine Maleate Market Research - PowerPoint PPT Presentation

About This Presentation
Title:

Chlorpheniramine Maleate Market Research

Description:

The chlorpheniramine maleate market size was valued at $468.6 million in 2022, and is projected to reach $751.4 million by 2032, growing at a CAGR of 4.9% from 2023 to 2032. – PowerPoint PPT presentation

Number of Views:0
Slides: 6
Provided by: ashish_allied
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Chlorpheniramine Maleate Market Research


1
Chlorpheniramine Maleate Market
  • The chlorpheniramine maleate market to reach
    751.4 million by 2032, growing at a CAGR of 4.9
    from 2023 to 2032. 

2
Prime determinants of growth 
  • Increase in the prevalence of allergic disorders
    such as allergic rhinitis, common cold, watery
    eyes, urticaria and various others, increase in
    urbanization and change in lifestyles and surge
    in technological advancement drive the growth of
    the global chlorpheniramine maleate market.
    However, potential side effects of
    chlorpheniramine maleate and availability of
    alternative medicines are hampering the
    chlorpheniramine maleate market growth. On the
    contrary, the growing level of air pollution in
    developing countries and surge in geriatric
    population are expected to offer remunerative
    opportunities for expansion of the
    chlorpheniramine maleate market during the
    forecast period.

3
(No Transcript)
4
North America to maintain its dominance by 2032
North America held the highest market share in
terms of revenue in 2022, accounting for around
two-fifths of the global chlorpheniramine maleate
market revenueand is likely to dominate the
market during the forecast period. The
chlorpheniramine maleate market in North
America is mainly driven by advancement in
healthcare infrastructure with easy access to
healthcare services, including OTC medications
for allergic conditions and increase in
prevalence of allergic condition in this region.
However, the Asia-Pacific region is expected to
witness the fastest CAGR of 5.5 from 2023 to
2032 owing to rise in prevalence of allergic
conditions, rise in demand for antihistaminic
drugs to treat allergic conditions, surge in
geriatric population and increase in air
pollution in developing countries such
as India, China, Japan, and South
Korea contribute to the growth of the
market.  For Purchase Inquiry- https//www.allied
marketresearch.com/purchase-enquiry/3975
5
Contact
  • David Correa
  • 5933 NE Win Sivers Drive205, Portland,
    OR 97220United StatesToll Free
    1-800-792-5285 UK 44-845-528-1300Hong Kong
    852-301-84916India (Pune) 91-20-66346060Fax
    1-855-550-5975help_at_alliedmarketresearch.comWeb
     https//www.alliedmarketresearch.com  Follow Us
    on LinkedIn Twitter
Write a Comment
User Comments (0)
About PowerShow.com